lorazepam + metoclopramide + diphenhydramine + prochlorperazine

This is a combination therapy consisting of four drugs—lorazepam, metoclopramide, diphenhydramine, and prochlorperazine—used primarily in acute care settings such as emergency departments for the management of severe migraine headaches and associated symptoms (such as nausea and vomiting). Each component has a distinct mechanism of action: - Lorazepam is a benzodiazepine that acts as a central nervous system depressant with anxiolytic, sedative, muscle relaxant, and antiemetic properties. - Metoclopramide is a dopamine D2 receptor antagonist with antiemetic and prokinetic effects. - Diphenhydramine is an antihistamine (H1 receptor antagonist) with anticholinergic properties; it is often co-administered to reduce the risk of extrapyramidal symptoms (EPS), particularly akathisia induced by dopamine antagonists like prochlorperazine or metoclopramide[1][3][4]. - Prochlorperazine is a phenothiazine derivative that acts primarily as an antidopaminergic agent at D2 receptors in the chemoreceptor trigger zone to control nausea/vomiting and also has antipsychotic activity[5]. This multi-drug regimen targets both headache pain (especially migraines) and associated gastrointestinal symptoms while minimizing adverse effects such as EPS. The combination may be used when monotherapy or dual therapy fails or when rapid symptom control is required.